FK506: the promise and the paradox.
作者信息
White D J
出版信息
Clin Exp Immunol. 1991 Jan;83(1):1-3. doi: 10.1111/j.1365-2249.1991.tb05578.x.
Abstract
摘要
相似文献
1
FK506: the promise and the paradox.他克莫司：前景与矛盾
Clin Exp Immunol. 1991 Jan;83(1):1-3. doi: 10.1111/j.1365-2249.1991.tb05578.x.
2
The complications of newer transplant antirejection drugs: treatment with cyclosporin A, OKT3, and FK506.新型移植抗排斥药物的并发症：环孢素A、OKT3和FK506治疗
Adverse Drug React Acute Poisoning Rev. 1990 Autumn;9(3):123-55.
3
Interspecies comparison of the immunosuppressive efficacy and safety of FK 506.FK 506免疫抑制功效及安全性的种间比较
Transplant Proc. 1990 Feb;22(1):100-5.
4
Comparative efficacy of immunosuppressive drugs in xenografting.
Transplant Proc. 1990 Jun;22(3):1083-5.
5
The effects of FK 506 on renal function after liver transplantation.FK506对肝移植后肾功能的影响。
Transplant Proc. 1990 Feb;22(1):17-20.
6
A potent immunosuppressive effect of FK 506 in orthotopic liver transplantation in primates.FK506在灵长类动物原位肝移植中具有强大的免疫抑制作用。
Transplant Proc. 1990 Feb;22(1):66-71.
7
Histopathological study of canine pancreaticoduodenal allotransplantation with FK506, cyclosporine, and triple regimen immunosuppression.使用FK506、环孢素和三联疗法免疫抑制进行犬胰十二指肠同种异体移植的组织病理学研究。
Transplant Proc. 1991 Feb;23(1 Pt 2):1589-92.
8
[Indications for liver transplantation in adults].[成人肝移植的适应证]
J Chir (Paris). 1990 Jun-Jul;127(6-7):334-40.
9
FK 506--an investigational immunosuppressant.FK506——一种实验性免疫抑制剂。
Med Lett Drugs Ther. 1991 Oct 4;33(854):94.
10
Nephrotoxicity associated with cyclosporine and FK506.
Liver Transpl Surg. 1995 Sep;1(5 Suppl 1):11-9.
引用本文的文献
1
The changing face of liver transplantation.肝移植不断变化的面貌。
Gut. 1993 Mar;34(3):295-8. doi: 10.1136/gut.34.3.295.
2
FK506: therapeutic effects on lupus dermatoses in autoimmune-prone MRL/Mp-lpr/lpr mice.FK506：对自身免疫易感的MRL/Mp-lpr/lpr小鼠狼疮性皮肤病的治疗作用
Arch Dermatol Res. 1995;287(6):558-63. doi: 10.1007/BF00374076.
3
Genetics of human X-linked immunodeficiency diseases.人类X连锁免疫缺陷疾病的遗传学
Clin Exp Immunol. 1991 Aug;85(2):182-92. doi: 10.1111/j.1365-2249.1991.tb05702.x.
4
Characterisation of passively transferred antigen arthritis induced by methylated bovine serum albumin in the rat: effect of FK 506 on arthritis development.
Agents Actions. 1992 May;36(1-2):146-51. doi: 10.1007/BF01991242.
本文引用的文献
1
Human renal transplantation. I. Clinical experiences with six cases of renal homotransplantation.人类肾移植。一、6例同种肾移植的临床经验。
J Urol. 1963 Jan;89:13-24. doi: 10.1016/S0022-5347(17)64491-4.
2
Prolonged survival of human-kidney homografts by immunosuppressive drug therapy.通过免疫抑制药物疗法延长人肾同种移植的存活时间。
N Engl J Med. 1963 Jun 13;268:1315-23. doi: 10.1056/NEJM196306132682401.
3
Inhibition of the rejection of renal homografts in dogs by Burroughs Wellcome 57-322.
Surg Forum. 1961;12:118-20.
4
The rejection of renal homografts. Inhibition in dogs by 6-mercaptopurine.同种肾移植的排斥反应。6-巯基嘌呤对犬的抑制作用。
Lancet. 1960 Feb 20;1(7121):417-8. doi: 10.1016/s0140-6736(60)90343-3.
5
6
Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat.新型免疫抑制剂FK 506对大鼠异位心脏同种异体移植的影响。
Transplant Proc. 1987 Feb;19(1 Pt 2):1284-6.
7
FK 506 for liver, kidney, and pancreas transplantation.用于肝脏、肾脏和胰腺移植的FK 506。
Lancet. 1989 Oct 28;2(8670):1000-4. doi: 10.1016/s0140-6736(89)91014-3.
8
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes.免疫抑制剂FK506可选择性抑制早期T细胞活化基因的表达。
J Immunol. 1989 Jul 15;143(2):718-26.
9
10
Effect of FK506 in experimental organ transplantation.FK506在实验性器官移植中的作用。
Transplant Proc. 1988 Feb;20(1 Suppl 1):215-9.
Zotero 插件